Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Stellar Biotechnologies, Inc V.KLH

Sector: Healthcare | Sub-Sector: Biotechnology

Stellar Biotechnologies, Inc. is in the production of KLH, an immuno-stimulatory protein used in vaccines & other biomedical products. Its customers and co-research partners include multi-national pharmaceutical companies and among others.
Price: $1.73 | Change: +$0.15 | %Change: +9.49%
Volume: 342,214 | Day High/Low: 1.81/1.62 | 52 Week High/Low: 2.55/0.65

Snapshot

Last Traded: October 24, 2014 11:54 Transaction Volume: 342,214
Open: $1.73 Previous Close: $1.58
Bid: $1.70 Ask: $1.75
Bid Size: 3,000 Ask Size: 2,500
Market Cap: $137.4m Shares Out: 79.4m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • RE:RE:Remember BioSyn

    0 stars

    A monopoly of SCALABLE, DOCUMENTED KLH. Stellar has a tremendous business model that is SAFE. How does Biosyn document its KLH?

    2.5 stars


  • RE:Remember BioSyn

    3 stars

    Been trading in and out of Stellar.  I thought their story was too good to be true. Seems the difference is one of scale, i.e. Stellar...

    2 stars


  • RE:Remember BioSyn

    0 stars

    bxju - great finds once again! Nice job. I think it speaks volumes that biosyn KLH had the original contract but now that Biovest is...

    2.5 stars


  • RE:RE:RE:RE:Remember BioSyn

    0 stars

    Thanks. .for ur input. I....must ...put some of my serious money on this....but ...the way the sp move fast ...sometime makes it...

    2 stars


  • RE:RE:RE:Remember BioSyn

    0 stars

    I must admit it is a bit exciting news but no details in the PR. The price will go up and then come down on thin or absence of news. When...

    2.5 stars